Search details
1.
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC.
JCI Insight
; 7(3)2022 02 08.
Article
in English
| MEDLINE | ID: mdl-35132961
2.
Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer.
MAbs
; 13(1): 1857100, 2021.
Article
in English
| MEDLINE | ID: mdl-33397194
3.
Evaluation of Pyrrolobenzodiazepine-Loaded Nanoparticles: A Targeted Drug Delivery Approach.
J Pharm Sci
; 108(4): 1590-1597, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30472264
4.
Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies.
Cancer Res
; 77(10): 2686-2698, 2017 05 15.
Article
in English
| MEDLINE | ID: mdl-28283653
5.
Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody-Drug Conjugate Targeting 5T4.
Mol Cancer Ther
; 16(8): 1576-1587, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28522587
6.
Lipid- and polyion complex-based micelles as agonist platforms for TNFR superfamily receptors.
J Control Release
; 234: 104-14, 2016 07 28.
Article
in English
| MEDLINE | ID: mdl-27212104
7.
A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response.
Mol Cancer Ther
; 15(4): 689-701, 2016 04.
Article
in English
| MEDLINE | ID: mdl-26880266
8.
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
Cancer Cell
; 29(1): 117-29, 2016 Jan 11.
Article
in English
| MEDLINE | ID: mdl-26766593
9.
Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse models.
Neoplasia
; 17(8): 661-70, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26408258
10.
Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells.
Leukemia
; 33(3): 766-771, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30315237
11.
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
Cancer Cell
; 35(6): 948-949, 2019 Jun 10.
Article
in English
| MEDLINE | ID: mdl-31185215
Results
1 -
11
de 11
1
Next >
>>